Adenosine and adenosine receptors in the cardiovascular system: biochemistry, physiology, and pharmacology.
about
Molecular cloning and characterization of a nitrobenzylthioinosine-insensitive (ei) equilibrative nucleoside transporter from human placentaAdenosine infusion increases plasma levels of VEGF in humans.Hypoxia induces cardiac malformations via A1 adenosine receptor activation in chicken embryosActivation of protein kinase B by the A(1)-adenosine receptor in DDT(1)MF-2 cellsDoes a selective adenosine A(1) receptor agonist protect against exercise induced ischaemia in patients with coronary artery disease?Identification of Cys140 in helix 4 as an exofacial cysteine residue within the substrate-translocation channel of rat equilibrative nitrobenzylthioinosine (NBMPR)-insensitive nucleoside transporter rENT2Characterization of purine receptors in fetal lamb pulmonary circulationAlteration of glycogen and glucose metabolism in ischaemic and post-ischaemic working rat hearts by adenosine A1 receptor stimulationNucleoside transporter subtype expression and function in rat skeletal muscle microvascular endothelial cellsIdentification of amino acid residues responsible for the pyrimidine and purine nucleoside specificities of human concentrative Na(+) nucleoside cotransporters hCNT1 and hCNT2Correlation of transient adenosine release and oxygen changes in the caudate-putamen.Adenosine 2A receptor modulates inflammation and phenotype in experimental abdominal aortic aneurysmsPertussis toxin sensitive and insensitive effects of adenosine and carbachol in murine atria overexpressing A(1)-adenosine receptors.Functional studies in atrium overexpressing A1-adenosine receptors.Adenosine and the auditory system.Pacing-induced regional differences in adenosine receptors mRNA expression in a swine model of dilated cardiomyopathy.Adenosine A(2A) receptors mediate cardiovascular responses to hypoxia in fetal sheep.Cardiac purinergic signalling in health and diseaseHyperoxia Improves Hemodynamic Status During Head-up Tilt Testing in Healthy Volunteers: A Randomized StudyIdiopathic Paroxysmal Atrio-Ventricular Block. What is The Mechanism?Role of store-operated Ca(2+) entry in adenosine-induced vasodilatation of rat small mesenteric arteryTargeting Adenosine Receptors for the Treatment of Cardiac FibrosisInvolvement of A1 adenosine receptors in altered vascular responses and inflammation in an allergic mouse model of asthma.Inhibiting protease-activated receptor 4 limits myocardial ischemia/reperfusion injury in rat hearts by unmasking adenosine signaling.Adenosine and chronic ischemia of the lower limbs.Evidence that the acute phase of ischemic preconditioning does not require signaling by the A 2B adenosine receptorThe ENT family of eukaryote nucleoside and nucleobase transporters: recent advances in the investigation of structure/function relationships and the identification of novel isoforms.Adenosine receptors and vascular inflammationMultidrug resistance protein 4 mediates cAMP efflux from rat preglomerular vascular smooth muscle cells.A comparison of an A1 adenosine receptor agonist (CVT-510) with diltiazem for slowing of AV nodal conduction in guinea-pig.Role of A(2A)-adenosine receptor activation for ATP-mediated coronary vasodilation in guinea-pig isolated heartRole of central and peripheral adenosine receptors in the cardiovascular responses to intraperitoneal injections of adenosine A1 and A2A subtype receptor agonists.Adenosine mediates relaxation of human small resistance-like coronary arteries via A2B receptorsThe association of ADORA2A and ADORA2B polymorphisms with the risk and severity of chronic heart failure: a case-control study of a northern Chinese population.Acute adenosinergic cardioprotection in ischemic-reperfused hearts.Nucleoside anticancer drugs: the role of nucleoside transporters in resistance to cancer chemotherapy.Adenosine receptor agonists: from basic medicinal chemistry to clinical development.B-Myb regulates the A(2B) adenosine receptor in vascular smooth muscle cellsSchwann Cells Metabolize Extracellular 2',3'-cAMP to 2'-AMP.A randomized, double-blind, placebo-controlled study of the safety and tolerance of regadenoson in subjects with stage 3 or 4 chronic kidney disease.
P2860
Q24312794-B8D66BCF-F9BF-4FAF-85B8-A1EB14055F9CQ24810899-7D4F7FE1-B022-45B9-A76D-438CED704691Q28264264-B3FB08FF-1BD1-4C69-BAB8-CC1F2E99A0D9Q28344379-63BA4EB6-061B-4AC1-BF77-512EA63DFFADQ28345211-B4675E54-EF3F-4918-97AE-CF3136015A2AQ28345550-4C83FF67-C779-4AFD-94E3-302AB7F66292Q28378454-444F3E81-1EBE-4A76-AD79-E488D4F4FF66Q28569545-9714E6B9-388D-464A-8180-1A717F53E6D1Q28570384-F816402A-1F30-45C3-BEFD-92D9934E4D63Q28610373-F94732CA-7597-412F-BCF3-7CEF74FDD9F5Q30276561-F01CFD46-36C4-4ACF-AE29-7CAD13951335Q30412759-2A561FF6-A426-4BFE-97D4-5616A1E274D3Q30443931-02E44096-20FF-4DED-BDF6-1A01F7433315Q30443941-E8C45E35-FEB3-4E43-9DB8-2892670AF522Q30482911-22532234-3BD6-4EDD-BB53-54AD84CFCAF9Q31105232-79087366-08E7-496D-B8BF-FB7455D260FEQ31722139-E16EFFBE-9671-490C-A3C8-EF7A38D356F5Q33165093-82269894-14F7-4933-85BB-7E71DF21BD70Q33166890-CB90382C-BE19-4CA8-84B3-C42A06815627Q33168633-6EDF0D96-CB16-4884-B78A-EAE76040E55BQ33442747-FB3F858E-69FF-4A9F-98FC-B014B5BF5481Q33639481-8B69A7DB-315C-4959-A484-A6D2E729FA3EQ33994883-1940C4C3-6370-4683-BB77-A652A2F8B06DQ34108989-F24380DC-F057-43FF-A787-A48571C514C4Q34158939-128C8DD4-2D45-45E9-BAF8-8BC27B173C55Q34216786-AD45B397-A5EC-4FB6-84DD-D4CB0C5B43F3Q34276389-1C773AE2-A8C8-4D9F-8F5F-6747579CE588Q34440546-02FA40C0-D381-4A49-8808-200E4FCF172FQ34746302-4EDB17D0-1007-45FE-A2B8-F09A20330BBAQ35028359-B8505EB3-8D93-4A95-89A8-9213709958BEQ35042386-4D6A1A10-8468-4F74-A159-9DBCBB9E2AA9Q35048671-F2827466-C8BF-4903-AA51-0AF136A4F13AQ35056733-E1F16828-6788-4A53-BFD7-A5174E9EAF5DQ35138929-AEA79BDD-356E-4CE9-BD4E-38FFA1276865Q35560907-400CAC43-1A64-4AD7-9630-A46F97106BA0Q35567292-D018828F-972D-44EE-9F7A-3E4918D6EC3EQ35602688-058070A4-04DD-481F-9777-C8232331611AQ35829870-2C369367-0DFF-40CF-BEB2-B0CEFAB12818Q35897785-016E9741-B999-463D-9E93-9AFF16FB1D6AQ35904476-C3D5544B-79FA-45B9-AB14-20A964ADE828
P2860
Adenosine and adenosine receptors in the cardiovascular system: biochemistry, physiology, and pharmacology.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Adenosine and adenosine recept ...... physiology, and pharmacology.
@en
type
label
Adenosine and adenosine recept ...... physiology, and pharmacology.
@en
prefLabel
Adenosine and adenosine recept ...... physiology, and pharmacology.
@en
P1476
Adenosine and adenosine recept ...... physiology, and pharmacology.
@en
P2093
J C Shryock
L Belardinelli
P356
10.1016/S0002-9149(97)00256-7
P407
P577
1997-06-01T00:00:00Z